# Therapy to Elevate CD4 Counts in HIV-1 Disease

> **NCT01370018** · PHASE2,PHASE3 · COMPLETED · sponsor: **Institute for Human Genetics and Biochemistry** · enrollment: 4 (actual)

## Conditions studied

- HIV Disease

## Interventions

- **BIOLOGICAL:** alpha-1-Proteinase Inhibitor

## Key facts

- **NCT ID:** NCT01370018
- **Lead sponsor:** Institute for Human Genetics and Biochemistry
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370018, "Therapy to Elevate CD4 Counts in HIV-1 Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01370018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*